Area of research
Endocrinology, Diabetes and Metabolism · Pediatrics, Perinatology and Child Health
Research interest
Research interests include Growth Hormone and Insulin-like Growth Factors, Pituitary Gland Disorders and Treatments, Childhood Cancer Survivors' Quality of Life, and Estrogen and related hormone effects.
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia
Specialized post-arterial capillaries facilitate adult bone remodelling
Long-Acting Growth Hormone Therapy in Pediatric Growth Hormone Deficiency: A Consensus Statement
Weekly Somapacitan in GH Deficiency: 4-Year Efficacy, Safety, and Treatment/Disease Burden Results From REAL 3
Development of a Minimum Dataset for the Monitoring of Recombinant Human Growth Hormone Therapy in Children with Growth Hormone Deficiency: A GloBE-Reg Initiative
THU166 A Minimum Data Set For The Monitoring Of Recombinant Human Growth Hormone (rhGH) Therapy In Children With Growth Hormone Deficiency (GHD)—A GloBE-Reg Initiative
Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement
Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement
Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement
Long-Term Safety of Growth Hormone Treatment in Childhood: Two Large Observational Studies: NordiNet IOS and ANSWER
Effective GH Replacement With Once-weekly Somapacitan vs Daily GH in Children with GHD: 3-year Results From REAL 3
Bone health in glucocorticoid-treated childhood acute lymphoblastic leukemia
Long-term mortality after childhood growth hormone treatment: the SAGhE cohort study
Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 Trial
Association of Childhood Growth Hormone Treatment With Long-term Cardiovascular Morbidity
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia
A radical switch in clonality reveals a stem cell niche in the epiphyseal growth plate
Secular Trends in Pubertal Growth Acceleration in Swedish Boys Born From 1947 to 1996
Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study
The Physiology of Childhood Growth: Hormonal Regulation
Somapacitan, a once‐weekly reversible albumin‐binding <scp>GH</scp> derivative, in children with <scp>GH</scp> deficiency: A randomized dose‐escalation trial
Mortality Is Not Increased in Recombinant Human Growth Hormone-treated Patients When Adjusting for Birth Characteristics
Short and tall stature: a new paradigm emerges
GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults
Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth Hormone
Short Stature in KBG Syndrome: First Responses to Growth Hormone Treatment
Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures
Mutations in SLC34A3/NPT2c Are Associated with Kidney Stones and Nephrocalcinosis
Common DNA variants predict tall stature in Europeans
Long-Term Mortality and Causes of Death in Isolated GHD, ISS, and SGA Patients Treated with Recombinant Growth Hormone during Childhood in Belgium, The Netherlands, and Sweden: Preliminary Report of 3 Countries Participating in the EU SAGhE Study